Home / Business and Economy / Zenas BioPharma CEO Buys 60K Shares
Zenas BioPharma CEO Buys 60K Shares
21 Jun
Summary
- CEO Leon Moulder Jr. purchased 60,000 Zenas BioPharma shares.
- The transaction value was approximately $1 million based on the average price.
- This purchase aligns with Moulder's recent buying trends over the past year.
Leon O. Molder Jr., CEO of Zenas BioPharma (NASDAQ:ZBIO), has significantly increased his holdings by purchasing 60,000 shares. This transaction, executed on the open market, occurred at a weighted average price of $16.88 per share. The total value of this purchase is approximately $1 million.
This recent acquisition aligns with Moulder's consistent insider buying activity observed over the last year. The 60,000-share purchase is comparable to several other substantial trades, suggesting a sustained accumulation strategy rather than a departure from his established behavior. Moulder's direct ownership now stands at 423,155 shares, with his total beneficial ownership, including shares held through a trust, surpassing 520,000 shares. He also holds an additional 1,786,039 shares indirectly via Tellus BioVentures LLC.
The market context for this purchase is notable, as Zenas BioPharma's stock has shown a 53.6% one-year total return as of the transaction date. Moulder's elevated trade size reflects his increased capacity rather than a shift in his consistent buying cadence.
